BMJ
Doctor-pharma relationships ‘can’t be trusted’
January 16, 2014Sales and Marketing BMJ, NHS, doctors, pharma
A US doctor has warned that patients will lose trust in healthcare professionals if they do not disclose the extent …
Pharma displaying ‘pathological lack of corporate integrity’
December 19, 2013BMJ, FDA, wolfe. pharma
The system that hands out financial penalties to drug companies for illegal activities is failing to deter companies from repeatedly …
NICE must get tougher on pharma, urges BMJ journal
December 16, 2013Sales and Marketing BMJ, NHS, NICE, pharma
The UK should have one universal health technology assessor which should seek to tighten up rules on whether new drugs …
Unpublished trials ‘violates ethical obligation’ to patients
October 30, 2013Research and Development, Sales and Marketing BMJ, Goldacre, all trials, trials
A new study published in the BMJ has found almost one in three (29%) of large clinical trials remain unpublished …
Open access splits researchers
October 24, 2013Medical Communications, Research and Development, Sales and Marketing BMJ, open access, publishing, research
Small medical research charities are worried that the extra costs of open access publishing will have a significant impact on …
Mid Staffs not only ‘dark spot’ in NHS
September 10, 2013Medical Communications, Sales and Marketing BMJ, Mid Staffs, NHS
The scandal of poor patient care at the Mid Staffordshire NHS Foundation Trust is likely to be far from an …
Doctor questions FDA’s diet drug approvals
August 23, 2013Research and Development, Sales and Marketing BMJ, Belviq, EMA, FDA, Vivus, diet pills, obesity
BMJ appoints US managing director
August 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMJ, Campbell
Medical journal BMJ has hired Glen Campbell from Elsevier to be its US managing director. Campbell joins BMJ on 2 …
Diabetes drug risks fuel transparency debate
June 12, 2013Research and Development, Sales and Marketing BMJ, Channel 4, all trials, diabetes, transaprency
A new investigation by Channel 4’s Dispatches and the British Medical Journal is demanding that all trial data be released …
Roche increases data access
February 27, 2013Research and Development, Sales and Marketing ABPI, BMJ, Goldacre, Roche
Roche has launched a new process designed to enable greater access to its clinical trial data for researchers from outside …
Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate
February 27, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead
In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …
Roche to release Tamiflu data
November 23, 2012Sales and Marketing BMJ, Cochrane, Goldacre, NHS, Roche, Tamiflu
Roche has said it will let researchers have access to more data on its influenza vaccine Tamiflu, apparently under pressure …
BMJ: diabetes post-marketing studies used to boost sales
June 14, 2012Sales and Marketing BMJ, Edwin Gale, Novo Nordisk, post-marketing
The use of post-marketing studies for diabetes is being used to sell more medicines rather than for science, according to …
Mobile monitoring of asthma ‘no better’ than traditional methods
March 26, 2012Medical Communications BMJ, Mobile monitoring, apps, asthma, smartphone
Mobile phone monitoring of asthma is ‘more expensive and no better than paper monitoring’, says new research. Findings published in …
NHS reforms criticised by healthcare journals
January 31, 2012Sales and Marketing BMJ, GPs, Lansley, NHS reforms, nursing times
A trio of leading healthcare journals has come out against the government’s NHS reforms. The British Medical Journal is leading …
Latest content
Five Facts about cardiovascular disease
